More REMS Could Result From FDA’s Safe Use Initiative

Washington Drug Letter
A A
The number of required risk evaluation and mitigation strategies (REMS) may increase under the Safe Use Initiative launched by the FDA last week.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00